ArticleFrontiers in oncology2026
Adrenal cortical adenoma-cavernous hemangioma collision tumor: a case report.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Adrenal collision tumors (ACTs) are rare entities defined by the coexistence of two histologically distinct, adjacent tumors within a single adrenal gland. Accurate preoperative diagnosis is crucial for management but remains challenging. We present a rare case of ACT in a 49-year-old woman with a three-year history of limb weakness. Imaging revealed a well-defined right adrenal mass with two distinct components. On detailed multiplanar reconstruction, the cortical adenoma component was located in the lateral (outer) portion of the right adrenal gland, occupying the superior-posterior aspect and abutting the perirenal fat (approximately 35% of total tumor volume). The cavernous hemangioma component was located in the medial (inner) portion, occupying the central and inferior-anterior aspect adjacent to the inferior vena cava (approximately 65% of total tumor volume). The two components met at a well-defined planar interface oriented obliquely from superolateral to inferomedial, without evidence of infiltration. CT and MRI demonstrated distinct imaging characteristics for each component. Pathological examination confirmed the diagnosis, demonstrating a cortical adenoma coexisting with a cavernous hemangioma, sharply demarcated by a fibrous septum. This case underscores the importance of recognizing the characteristic imaging patterns of different tumor components within a single adrenal lesion. When atypical features are present within an otherwise typical tumor, an ACT should be considered to guide appropriate clinical management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.